# IRulya Therapeutics Inc.: Form DEF 14A, filed Apr 23, 2025

- Company: [IRulya Therapeutics Inc.](/companies/irla.md) (CIK 1662774)
- Form: DEF 14A
- Filed: 2025-04-23
- Accepted by EDGAR: Apr 23, 2025, 16:00 ET
- Period: 2025-06-04
- Accession: 0001662774-25-000025
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662774/000166277425000025/qncx-20250423.htm

Filed Apr 23, 2025.
Source: SEC EDGAR, the filing index for accession 0001662774-25-000025. Last ingested by Listed: Nov 15, 2026, 02:27 ET. No prices; not investment advice.
